Johnson & Johnson director awarded deferred share units

HEWSON MARILLYN A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

HEWSON MARILLYN A reported acquisition or exercise transactions in this Form 4 filing.

Johnson & Johnson director Marillyn A. Hewson reported routine compensation-related awards of Deferred Share Units (DSUs), not open-market stock trades. On March 10, 2026, she received 206.4920 DSUs valued at $242.1400 each, bringing her holdings to 14512.9400 DSUs.

The filing also reflects a prior DSU award of 75.2560 units on March 4, 2025 at $166.1000 per unit. These DSUs represent deferred cash retainers under the company’s Deferred Fee Plan for Directors, are settled in cash when her board service ends, and track the fair market value of one share of common stock plus dividend equivalents.

Insider Trade Summary

Grant/Award: 281.748 shares

Grant/Award 2 txns

Insider HEWSON MARILLYN A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	206.492	$242.14	$50K
Grant/Award	Deferred Share Units	75.256	$166.10	$13K

Holdings After Transaction: Deferred Share Units — 28,819.3887 contracts (Direct)

Footnotes (3)

1. F1. Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
2. F2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
3. F3. Acquisition of DSUs for deferral of cash retainer under the Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Marillyn A. Hewson report in this Johnson & Johnson (JNJ) Form 4?

Marillyn A. Hewson reported awards of Deferred Share Units (DSUs) as part of her director compensation. These are bookkeeping entries linked to her cash retainer, not open-market purchases or sales of Johnson & Johnson common stock.

How many Deferred Share Units did the JNJ director receive and at what values?

She received 206.4920 DSUs on March 10, 2026 at $242.1400 per unit and 75.2560 DSUs on March 4, 2025 at $166.1000 per unit. Each DSU mirrors the fair market value of one Johnson & Johnson common share.

Does this Johnson & Johnson Form 4 show the director buying or selling JNJ stock?

No. The filing shows grants of Deferred Share Units classified as compensation-related acquisitions. These DSUs are part of a deferred fee plan and are settled in cash, so they do not represent direct buying or selling of JNJ common stock.

What are Deferred Share Units (DSUs) in the context of JNJ’s director compensation?

Deferred Share Units are bookkeeping units tied to the value of Johnson & Johnson common stock, used to defer a director’s cash retainer. They accumulate dividend equivalents and are paid out in cash based on share value when board service ends.

When will Marillyn A. Hewson’s Johnson & Johnson DSUs be settled?

Her DSUs are scheduled to be settled in cash upon termination of her directorship. At that time, each DSU will pay the fair market value of one JNJ share on the business day before the settlement date, including prior dividend equivalents.

How many Deferred Share Units does the JNJ director hold after the latest transaction?

After the March 10, 2026 award, Marillyn A. Hewson holds a reported total of 14512.9400 Deferred Share Units. This reflects cumulative DSU grants and dividend equivalents accrued under Johnson & Johnson’s Deferred Fee Plan for Directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/12/2026 - 09:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HEWSON MARILLYN A

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NJ 08933

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	03/04/2025		A		75.256		(1)	(1)	Common Stock	75.256	$166.1	14,306.4487(2)	D
Deferred Share Units	(3)	03/10/2026		A		206.492		(3)	(3)	Common Stock	206.492	$242.14	14,512.94(2)	D

Explanation of Responses:

1. Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

3. Acquisition of DSUs for deferral of cash retainer under the Plan.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Marillyn A. Hewson	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.